Kronik Koroner Sendrom Tanısı Alan Hastalarda D Vitamini Eksikliği ile CHA2DS2-VASc Skoru Arasındaki İlişki
Amaç: Kronik koroner sendrom (KKS) tanılı hasta grubunda D vitamini eksikliği ile CHA2DS2-VASc skoru arasındaki ilişkiyi tespit etmeyi amaçladık.
Gereç ve Yöntem: Çalışmaya KKS tanısı konmuş ve koroner anjiografi uygulanmış ve kritik koroner arter darlığı saptanan 147 hasta retrospektif olarak alındı. Hastaların CHA2DS2-VASc skorları hesaplandı. Laboratuvar bulguları, D vitamin düzeyleri ve ekokardiyografi parametreleri kaydedildi. CHA2DS2-VASc skoruna göre;
The Relationship Between Vitamin D Deficiency And CHA₂DS₂-VASc Score in Chronic Coronary Syndrome
Objective: To assess the relationship between Vitamin D level and CHA2DS2-VASc score in patients with chronic coronary syndrome (CCS).
Methods:A total of 147 participants with CCS who underwent coronary angiography and had critical coronary artery stenosis were retrospectively enrolled in the study. Patients’ CHA2DS2-VASc scores were measured. Laboratory parameters including vitamin D and echocardiographic findings were recorded. Participants were divided into two groups according to CHA2DS2-VASc score, CHA2DS2-VASc score
___
- January CT, Wann LS, Alpert JS Calkins H, Cigarroe JE, Cleveland JC, et al. 2014 AHA/ACC/HRS Guideline for the Management of Patients With Atrial Fibrillation: A Report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines and the Heart Rhythm Society. J Am Coll Cardiol, 2014; 64: e1-e76. https://doi.org/10.1016/j.jacc.2014.03.022.
- Biancari F, Asim Mahar MA, Kangasniemi OP. CHADS(2) and CHA(2)DS(2)-VASc scores for prediction of immediate and late stroke after coronary artery bypass graft surgery. J Stroke Cerebrovasc Dis, 2013; 22: 1304-1311. https://doi.org/10.1016/j.jstrokecerebrovasdis.2012.11.004.
- Welles CC, Whooley MA, Na B, Ganz P, Schiller NB, Turakhia MP. The CHADS2 score predicts ischemic stroke in the absence of atrial fibrillation among subjects with coronary heart disease: data from the Heart and Soul Study. Am Heart J, 2011; 162: 555-561. https://doi.org/10.1016/j.ahj.2011.05.023.
- Cerit L, Kemal H, Gulsen K, Ozcem B, Cerit Z, Duygu H. Relationship between vitamin D and the development of atrial fibrillation after on-pump coronary artery bypass graft surgery. Cardiovasc J Afr. 2017;28(2):104-7 https://doi.org/10.5830/CVJA-2016-064.
- Sadiya A, Ahmed SM, Skaria S, Abusnana S. Vitamin D status and its relationship with metabolic markers in persons with obesity and type 2 diabetes in the UAE: a cross-sectional study. J Diabetes Res 2014;2014:869307. https://doi.org/10.1155/2014/869307.
- Ginde AA, Scragg R, Schwartz RS, Camargo CA Jr. Prospective study of serum 25-hydroxyvitamin D level, cardiovascular disease mortality, and all-cause mortality in older U.S. adults. J Am Geriatr Soc. 2009;57:1595-603. https://doi.org/10.1111/j.1532-5415.2009.02359.x.
- Kunadian V, Ford GA, Bawamia B, Qiu W, Manson JE. Vitamin D deficiency and coronary artery disease: a review of the evidence. Am Heart J 2014;167:283-91. https://doi.org/10.1016/j.ahj.2013.11.012.
- Demir M, Uyan U, Melek M. The effects of vitamin D deficiency on atrial fibrillation. Clin Appl Thromb Hemost. 2014;20:98-103. https://doi.org/10.1177/1076029612453762.
- Wang C. Role of vitamin D in cardiometabolic diseases. J Diabetes Res. 2013;2013:243934. https://doi.org/10.1155/2013/243934.
- Knuuti J, Wijns W, Saraste A, Capodanno D, Barbato E, Funck-Brentano C, et al. ESC Scientific Document Group. 2019 ESC Guidelines for the diagnosis and management of chronic coronary syndromes. Eur Heart J 2020; 41: 407- 477. https://doi.org/10.1093/eurheartj/ehz425.
- Tei C, Ling LH, Hodge DO, Bailey KR, Oh JK, Rodeheffer RJ, et al. New index of combined systolic and diastolic myocardial performance: a simple and reproducible measure of cardiac function a study in normals and dilated cardiomyopathy. J Cardiol 1995;26:357-66.
- Lip GY, Nieuwlaat R, Pisters R, Lane DA, Crijns HJGM. Refining clinical risk stratification for predicting stroke and thromboembolism in atriyal fibrillation using a novel risk factor-based approach: the euro heart survey on atriyal fibrillation. Chest. 2010;137:263-272. https://doi.org/10.1378/chest.09-1584.
- Lloyd-Jones D, Adams R, Carnethon M, Simone G, Ferguson TB, Flegal K, et al. Heart disease and stroke statistics--2009 update: A report from the American Heart Association statistics committee and stroke statistics subcommittee. Circulation. 2009; 119:e21-181. https://doi.org/10.1161/CIRCULATIONAHA.108.191261.
- Kannel WB, McGee DL. Diabetes and cardiovascular disease - Framingham Study. Jama. 1979; 241:2035-2038. https://doi.org/10.1001/jama.241.19.2035.
- Karthikeyan G, Eikelboom JW. The CHADS2 score for stroke risk stratification in atrial fibrillation-friend or foe? Thromb Haemost. 2010;104:45-8. https://doi.org/10.1160/TH09-11-0757.
- Zhou X, Cao K, Kou S, Qu S, Li H, Yu Y, et al. Usefulness of CHADS2 score for prognostic stratification of patients with coronary artery disease: a systematic review and meta-analysis of cohort studies. Int J Cardiol 2017;228:906-911. https://doi.org/10.1016/j.ijcard.2016.11.114.
- Kurtul A, Yarlioglues M, Duran M. Predictive value of CHA2DS2-VASC score for contrast-induced nephropathy after percutaneous coronary intervention for acute coronary syndrome. Am J Cardiol. 2017;119(6):819-25. DOI: https://doi.org/10.1016/j.amjcard.2016.11.033.
- Ünal S, Açar B, Yayla Ç, Balci MM, Ertem A, Kara M et al. Importance and usage of the CHA2DS2-VASc score in predicting acute stent thrombosis. Coron Artery Dis. 2016;27(6):478-82. https://doi.org/10.1097/MCA.0000000000000388.
- Ipek G, Onuk T, Karatas MB, Gungor B, Osken A, Keskin M, et al. CHA2DS2-VASc score is a predictor of no-reflow in patients with ST-segment elevation myocardial infarction who underwent primary percutaneous intervention. Angiology. 2016;67(9):840-5. https://doi.org/10.1177/0003319715622844.
- Aksoy F, Bağcı A. Evaluation of CHA2DS2-VASc and ATRIA Scores in Patients With Acute Coronary Syndrome. Sdü Sağlık Bilimleri Dergisi / Cilt 10 Sayı 4 / 2019. https://doi.org/10.22312/sdusbed.551930
- D’Ascenzo F, Biondi-Zoccai G, Moretti C, Bollati M, Omede P, Sciuto F, et al., TIMI, GRACE and alternative risk scores in acute coronary syndromes: a meta-analysis of 40 derivation studies on 216,552 patients and of 42 validation studies on 31,625 patients, Control. Clin. Trials 33 (3) (2012) 507-514. https://doi.org/10.1016/j.cct.2012.01.001.
- Verdoia M, Nardin M, Rolla R, Negro F, Gioscia R, Afifeh AMS, et al. Prognostic impact of Vitamin D deficiency in patients with coronary artery disease undergoing percutaneous coronary intervention Eur J Intern Med. 2020 Aug 20;S0953-6205(20)30332-0. https://doi.org/10.1016/j.ejim.2020.08.016.
- Kendrick J, Targher G, Smits G, Chonchol M. 25-Hydroxyvitamin D deficiency is independently associated with cardiovascular disease in the third national health and nutrition examination survey. Atherosclerosis 2009;205:255-60. https://doi.org/10.1016/j.atherosclerosis.2008.10.033.
- Seker T, Gur M, Yuksel Kalkan G, Kuloglu O, Yildiz Koyunsever N, Yildiray Sahin D, et al. Serum 25-hydroxyvitamin D level and extent and complexity of coronary artery disease. J Clin Lab Anal. 2014, 28: 52–58. pmid:24375475. https://doi: 10.1002/jcla.21643.
- Brondum-Jacobsen P, Nordestgaard BG, Schnohr P, Benn M. 25-hydroxyvitamin D and symptomatic ischemic stroke: An original study and meta-analysis. Ann. Neurol. 2013, 73, 38-47. https://doi.org/10.1002/ana.23738.
- Liu X, Wang W, Tan Z, Zhu X, Liu M, Wan R, et al. The relationship between vitamin D and risk of atrial fibrillation: a dose-response analysis of observational studies. Nutr J. 2019;18:73. https://doi.org/10.1186/s12937-019-0485-8.
- Bjelakovic G, Gluud LL, Nikolova D, Whitfield K, Wetterslev J, Simonetti RG, et al. Vitamin D supplementation for prevention of mortality in adults. Cochrane Database Syst Rev 2014;1:CD007470. https://doi.org/10.1002/14651858.CD007470.pub3.
- LeBoff MS, Murata EM, Cook NR, Cawthon P, Chou SH, Kotler G, et al. VITamin D and OmegA-3 TriaL (VITAL): Effects of Vitamin D Supplements on Risk of Falls in the US Population. J. Clin. Endocrinol. Metab. 2020, 105. https://doi: 10.1210/clinem/dgaa311.
- Albert CM, Cook NR, Pester J, MoortHy MV, Ridge C, Danik JS, et al. Effect of marine omega-3 fatty acid and vitamin D supplementation on incident atrial fibrillation: a randomized clinical trial. JAMA. 2021;325(11):1061–1073. https://doi: 10.1001/jama.2021.1489.
- Aurigemma GP, de Simone G, Fitzgibbons TP. Cardiac remodeling in obesity. Circ Cardiovasc Imaging 2013;6:142-152. https://doi.org/10.1161/CIRCIMAGING.111.964627.
- Dublin S, French B, Glazer NL, Wiggins KL, Lumley T, Psaty BM, et al. Risk of new-onset atrial fibrillation in relation to body mass index. Arch Intern Med 2006;166:2322-2328. https://doi.org/10.1001/archinte.166.21.2322.
- Wan H, Wu S, Wang J, Yang Y, Zhu J, Shao X, et al. Body mass index and the risk of all-cause mortality among patients with nonvalvular atrial fibrillation: a multicenter prospective observational study in China. Eur J Clin Nutr. 2017;71(4):494-9. https://doi.org/10.1038/ejcn.2016.183.
- Lajous M, Banack HR, Kaufman JS, Hernan MA. Should patients with chronic disease be told to gain weight? The obesity paradox and selection bias. Am J Med 2015;128(4):334-6. https://doi.org/10.1016/j.amjmed.2014.10.043.
- Aksoy F, Guler S, Kahraman F, Oskay T, Varol E. The Relation Between Echocardiographic Epicardial Fat Thickness and CHA2DS2-VASc Score in Patients with Sinus Rhythm. Braz J Cardiovasc Surg. Jan-Feb 2019;34(1):41-47. https://doi: 10.21470/1678-9741-2018-0230.